These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 12692208)

  • 1. Inhibition of respiratory syncytial virus fusion by the small molecule VP-14637 via specific interactions with F protein.
    Douglas JL; Panis ML; Ho E; Lin KY; Krawczyk SH; Grant DM; Cai R; Swaminathan S; Cihlar T
    J Virol; 2003 May; 77(9):5054-64. PubMed ID: 12692208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecules VP-14637 and JNJ-2408068 inhibit respiratory syncytial virus fusion by similar mechanisms.
    Douglas JL; Panis ML; Ho E; Lin KY; Krawczyk SH; Grant DM; Cai R; Swaminathan S; Chen X; Cihlar T
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2460-6. PubMed ID: 15917547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VP-14637 ViroPharma.
    McKimm-Breschkin J
    Curr Opin Investig Drugs; 2000 Dec; 1(4):425-7. PubMed ID: 11249694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion Process.
    Perron M; Stray K; Kinkade A; Theodore D; Lee G; Eisenberg E; Sangi M; Gilbert BE; Jordan R; Piedra PA; Toms GL; Mackman R; Cihlar T
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1264-73. PubMed ID: 26666922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell fusion assay by expression of respiratory syncytial virus (RSV) fusion protein to analyze the mutation of palivizumab-resistant strains.
    Yasui Y; Yamaji Y; Sawada A; Ito T; Nakayama T
    J Virol Methods; 2016 May; 231():48-55. PubMed ID: 26794681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors.
    Yan D; Lee S; Thakkar VD; Luo M; Moore ML; Plemper RK
    Proc Natl Acad Sci U S A; 2014 Aug; 111(33):E3441-9. PubMed ID: 25092342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral activity and molecular mechanism of an orally active respiratory syncytial virus fusion inhibitor.
    Cianci C; Meanwell N; Krystal M
    J Antimicrob Chemother; 2005 Mar; 55(3):289-92. PubMed ID: 15681582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The core of the respiratory syncytial virus fusion protein is a trimeric coiled coil.
    Matthews JM; Young TF; Tucker SP; Mackay JP
    J Virol; 2000 Jul; 74(13):5911-20. PubMed ID: 10846072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual Inhibition of Human Parainfluenza Type 3 and Respiratory Syncytial Virus Infectivity with a Single Agent.
    Outlaw VK; Bottom-Tanzer S; Kreitler DF; Gellman SH; Porotto M; Moscona A
    J Am Chem Soc; 2019 Aug; 141(32):12648-12656. PubMed ID: 31268705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five Residues in the Apical Loop of the Respiratory Syncytial Virus Fusion Protein F
    Hicks SN; Chaiwatpongsakorn S; Costello HM; McLellan JS; Ray W; Peeples ME
    J Virol; 2018 Aug; 92(15):. PubMed ID: 29743373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations That Increase the Stability of the Postfusion gp41 Conformation of the HIV-1 Envelope Glycoprotein Are Selected by both an X4 and R5 HIV-1 Virus To Escape Fusion Inhibitors Corresponding to Heptad Repeat 1 of gp41, but the gp120 Adaptive Mutations Differ between the Two Viruses.
    Zhuang M; Vassell R; Yuan C; Keller PW; Ling H; Wang W; Weiss CD
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30894471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RFI-641 inhibits entry of respiratory syncytial virus via interactions with fusion protein.
    Razinkov V; Gazumyan A; Nikitenko A; Ellestad G; Krishnamurthy G
    Chem Biol; 2001 Jul; 8(7):645-59. PubMed ID: 11451666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate.
    Netter RC; Amberg SM; Balliet JW; Biscone MJ; Vermeulen A; Earp LJ; White JM; Bates P
    J Virol; 2004 Dec; 78(24):13430-9. PubMed ID: 15564453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Heptad Repeat C Domain of the Respiratory Syncytial Virus Fusion Protein Plays a Key Role in Membrane Fusion.
    Bermingham IM; Chappell KJ; Watterson D; Young PR
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29212939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses.
    Ohol YM; Wang Z; Kemble G; Duke G
    PLoS One; 2015; 10(12):e0144648. PubMed ID: 26659560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Resistance Assessment Following Administration of Respiratory Syncytial Virus (RSV) Fusion Inhibitor Presatovir to Participants Experimentally Infected With RSV.
    Stray K; Perron M; Porter DP; Anderson F; Lewis SA; Perry J; Miller M; Cihlar T; DeVincenzo J; Chien JW; Jordan R
    J Infect Dis; 2020 Oct; 222(9):1468-1477. PubMed ID: 31971597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both heptad repeats of human respiratory syncytial virus fusion protein are potent inhibitors of viral fusion.
    Wang E; Sun X; Qian Y; Zhao L; Tien P; Gao GF
    Biochem Biophys Res Commun; 2003 Mar; 302(3):469-75. PubMed ID: 12615056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of selective inhibition of respiratory syncytial virus by a benzodithiin compound (RD3-0028).
    Sudo K; Konno K; Watanabe W; Shigeta S; Yokota T
    Microbiol Immunol; 2001; 45(7):531-7. PubMed ID: 11529559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF1R is an entry receptor for respiratory syncytial virus.
    Griffiths CD; Bilawchuk LM; McDonough JE; Jamieson KC; Elawar F; Cen Y; Duan W; Lin C; Song H; Casanova JL; Ogg S; Jensen LD; Thienpont B; Kumar A; Hobman TC; Proud D; Moraes TJ; Marchant DJ
    Nature; 2020 Jul; 583(7817):615-619. PubMed ID: 32494007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two novel fusion inhibitors of human respiratory syncytial virus.
    Lundin A; Bergström T; Bendrioua L; Kann N; Adamiak B; Trybala E
    Antiviral Res; 2010 Dec; 88(3):317-24. PubMed ID: 20965215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.